𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Early relapse in a rectal cancer patient: Possible implication of circulating cancer stem cell

✍ Scribed by Chih-Yung Yang; Chi-Hung Lin; Dr. Jeng-Kai Jiang


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
117 KB
Volume
102
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Development of a membrane array-based mu
✍ Chau-Chyun Sheu; Ya-Ping Yu; Jong-Rung Tsai; Mei-Yin Chang; Shiu-Ru Lin; Jhi-Jhu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 373 KB 👁 2 views

## Abstract Combination of multiple mRNA markers has been largely investigated for detection of circulating cancer cells. However, current PCR‐based methods are relatively expensive and time consuming. The aim of this study was to develop a membrane array‐based multimarker assay for detection of ci

Overexpression of hypoxia-inducible fact
✍ Jean-Philippe Dales; Stéphane Garcia; Séverine Meunier-Carpentier; Lucile Andrac 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 372 KB

Hypoxia-inducible factor-1alpha (HIF-1alpha) is a transcription factor that is involved in tumour growth and metastasis by regulating genes involved in response to hypoxia. HIF-1alpha protein overexpression has been shown in a variety of human cancers, but only 2 studies have documented the prognost

Development of a high-throughput membran
✍ Chan-Hang Wu; Shiu-Ru Lin; Fang-Jung Yu; Deng-Chyang Wu; Yong-Sang Pan; Jan-Sing 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 374 KB 👁 1 views

## Abstract Recently several noninvasive methods have been employed to detect circulating tumor cells (CTCs) in cancer patients. In this study, we have developed a highly sensitive, high‐throughput colorimetric membrane‐array method that was designed to detect a panel of mRNA markers including huma

T cells reactive with HLA-A*0201 peptide
✍ Julia A. Coleman; Isabel Correa; Lucienne Cooper; Hermann R. Bohnenkamp; Richard 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 431 KB

## Abstract The nuclear protein PLU‐1/JARID1B/KDM5 is widely expressed in breast cancers while showing highly restricted expression in normal adult tissues. To investigate whether JARID1B is a potential target antigen for immunotherapy of breast cancer, we have analyzed the responses of CD8^+^ T ce